|

Chiglitazar Placebo Clinical Trials

1 actively recruiting trial

Also known as: simulant of chiglitazar

Pipeline

Phase 2: 1

Top Sponsors

  • Shanghai Jiao Tong University School of Medicine1

Indications

  • T2DM (Type 2 Diabetes Mellitus)1
  • Liver Disease1
  • MASH - Metabolic Dysfunction-Associated Steatohepatitis1
  • Diabetes1

Other1 trial

A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.